Source link : https://www.newshealth.biz/health-news/glp-1-labels-dont-reflect-trial-exclusions/
About a third of people eligible for glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications for weight loss via the products’ labels would have been excluded from the clinical trials that supported their safety and effectiveness, thereby creating the potential for harm, new research suggests. About a quarter of those with obesity but not diabetes […]
Author : News Health
Publish date : 2024-11-27 08:36:31
Copyright for syndicated content belongs to the linked Source.
inHealth